Suchergebnisse - "Reck, Martin"

PubPharm (586)

1

HERTHENA-Lung02 : phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI

enthalten in: Future oncology (London, England) | 2024

von Mok, T. | Jänne, P. | Nishio, M. | +10

2

TRIM11 expression in non-small cell lung cancer is associated with poor prognosis

enthalten in: Histology and histopathology | 2024

von Kuempers, C. | Jagomast, T. | Paulsen, F. | +9

3

Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade

enthalten in: Cancer cell | 2024

von Nabet, B. | Hamidi, H. | Lee, M. | +24

4

Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2) : A multicenter, randomized, double-blind, phase 3 trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Paz-Ares, L. | Goto, Y. | Wan-Teck Lim, D. | +15

5

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Carbone, D. | Ciuleanu, T. | Schenker, M. | +23

6

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Blasi, M. | Kuon, J. | Lüders, H. | +19

7

Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC : Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Reck, M. | Barlesi, F. | Yang, J. | +15

8

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC : A Phase 2 Randomized Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Vokes, E. | Mornex, F. | Sezer, A. | +17

9

SKYSCRAPER-02 : Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Rudin, C. | Liu, S. | Soo, R. | +19

10

Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. Reply

enthalten in: The New England journal of medicine | 2024

von Heymach, J. | Harpole, D. | Reck, M.

CommentOn: N Engl J Med. 2023 Nov 2;389(18):1672-1684. - PMID 37870974

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]